SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $396,063 | -92.9% | 15,387 | -92.8% | 0.00% | -93.9% |
| Q4 2022 | $5,576,726 | +14.4% | 214,407 | +25.5% | 0.03% | +22.2% |
| Q3 2022 | $4,876,000 | +45.1% | 170,901 | +25.2% | 0.03% | +28.6% |
| Q2 2022 | $3,361,000 | +422.7% | 136,515 | +1216.4% | 0.02% | +250.0% |
| Q4 2021 | $643,000 | -24.1% | 10,370 | -22.4% | 0.01% | -45.5% |
| Q3 2021 | $847,000 | -55.1% | 13,358 | -41.7% | 0.01% | -47.6% |
| Q2 2021 | $1,887,000 | -5.7% | 22,902 | -15.8% | 0.02% | -19.2% |
| Q1 2021 | $2,001,000 | +120.9% | 27,196 | +117.6% | 0.03% | +116.7% |
| Q4 2020 | $906,000 | +1252.2% | 12,496 | +794.5% | 0.01% | +1100.0% |
| Q3 2020 | $67,000 | -35.0% | 1,397 | -43.0% | 0.00% | -50.0% |
| Q2 2020 | $103,000 | +472.2% | 2,450 | +261.4% | 0.00% | – |
| Q1 2020 | $18,000 | – | 678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |